This work demonstrates that the hSOD1(G93A)-derived culture medium has a completely different secretome than the hSOD1(WT) counterpart and that the addition of MCM from healthy myocytes was capable of correcting the delayed in vitro myogenic program of ALS-related cells. The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.